Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Investing Activities (2016 - 2025)

Lipocine (LPCN) has disclosed Cash from Investing Activities for 13 consecutive years, with $701449.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities fell 31.4% year-over-year to $701449.0, compared with a TTM value of $5.1 million through Sep 2025, up 15.16%, and an annual FY2024 reading of $2.4 million, down 81.31% over the prior year.
  • Cash from Investing Activities was $701449.0 for Q3 2025 at Lipocine, down from $4.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.3 million in Q1 2022 and bottomed at -$34.0 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$507187.7, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities plummeted 971.15% in 2021, then skyrocketed 364.53% in 2022.
  • Year by year, Cash from Investing Activities stood at -$9.7 million in 2021, then skyrocketed by 126.7% to $2.6 million in 2022, then increased by 5.02% to $2.7 million in 2023, then plummeted by 72.09% to $761058.0 in 2024, then decreased by 7.83% to $701449.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for LPCN at $701449.0 in Q3 2025, $4.5 million in Q2 2025, and -$882073.0 in Q1 2025.